Comparing supervised and non-supervised exercise for improving balance and quality of life in diabetic neuropathy

Effect of Supervised in Comparison to Non-supervised Multicomponent Exercise Training on Balance and Quality of Life in Peripheral Diabetic Neuropathy

NA · Foundation University Islamabad · NCT06964542

This study is testing whether supervised exercise or non-supervised exercise helps improve balance and quality of life for older adults with diabetic neuropathy.

Quick facts

PhaseNA
Study typeInterventional
Enrollment30 (estimated)
Ages55 Years to 70 Years
SexAll
SponsorFoundation University Islamabad (other)
Locations1 site (Islamabad)
Trial IDNCT06964542 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to evaluate the effects of supervised versus non-supervised multicomponent exercise training on balance and quality of life in patients with peripheral diabetic neuropathy. Participants aged 55-70 with type 2 diabetes will be randomly assigned to either a supervised exercise group or a non-supervised exercise group. The study will assess outcomes using standardized tools such as the WHOQOL BREF, Berg Balance Scale, and Time Up and Go Test. The goal is to determine which exercise approach yields better improvements in strength, endurance, balance, and mobility.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 55-70 with a diagnosis of type 2 diabetes for at least 10 years and who meet specific screening criteria.

Not a fit: Patients with hypoglycemia, ischemic heart diseases, major orthopedic problems, or those unable to walk independently may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the quality of life and functional abilities of patients suffering from peripheral diabetic neuropathy.

How similar studies have performed: Previous studies have shown positive outcomes with supervised exercise interventions in similar populations, suggesting potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 55-70 years (both male and female)
* Diagnosed patients of diabetes type 2, 10 years after disease
* Completely assessed with Michigan Neuropathy Screening Instrument (MNSI) score scale and patients fulfilling this criterion will be included in this study
* Patients who are fulfilling PARQ will be included in study

Exclusion Criteria:

* Hypoglycemia
* Patient having ischemic heart diseases will not be included
* unable to walk independent
* major orthopedic problems (e.g. lower limb fractures)
* Diagnosed neurological and psychological patients

Where this trial is running

Islamabad

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Peripheral Diabetic Neuropathy, Endurance, Multicomponent exercise training, Diabetes Mellitus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.